Back to Index
Fariba Navid
Associate Professor of Clinical Pediatrics
CHL 4650 Sunset Blvd Off Campus Los Angeles
+1 323 361 2762


A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy. Int J Cancer. 2017 Oct 01; 141(7):1469-1477. View in: PubMed

FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma. J Nucl Med. 2017 Jun 13. View in: PubMed

Prospective study of neuropathic pain after definitive surgery for extremity osteosarcoma in a pediatric population. Pediatr Blood Cancer. 2017 Mar; 64(3). View in: PubMed

Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE). Ann Am Thorac Soc. 2016 Sep; 13(9):1575-85. View in: PubMed

Limited Margin Radiation Therapy for Children and Young Adults With Ewing Sarcoma Achieves High Rates of Local Tumor Control. Int J Radiat Oncol Biol Phys. 2016 Sep 01; 96(1):119-26. View in: PubMed

In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments. Cancer Res. 2016 Jul 01; 76(13):3929-41. View in: PubMed

Use of Quantitative Dynamic Contrast-Enhanced Ultrasound to Assess Response to Antiangiogenic Therapy in Children and Adolescents With Solid Malignancies: A Pilot Study. AJR Am J Roentgenol. 2016 May; 206(5):933-9. View in: PubMed

Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma. Pediatr Blood Cancer. 2016 08; 63(8):1381-6. View in: PubMed

Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma. Pediatr Blood Cancer. 2016 07; 63(7):1207-13. View in: PubMed

Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation. Br J Clin Pharmacol. 2016 Jan; 81(1):148-60. View in: PubMed

Pediatric Melanoma and Atypical Melanocytic Neoplasms. Cancer Treat Res. 2016; 167:331-69. View in: PubMed

Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI. Br J Cancer. 2015 Nov 03; 113(9):1282-8. View in: PubMed

Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory/recurrent solid tumors. J Pediatr Surg. 2015 Sep; 50(9):1484-9. View in: PubMed

Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients. Pediatr Blood Cancer. 2015 Sep; 62(9):1518-22. View in: PubMed

FDG PET/CT imaging of desmoplastic small round cell tumor: findings at staging, during treatment and at follow-up. Pediatr Radiol. 2015 Aug; 45(9):1308-15. View in: PubMed

Vincristine and Dactinomycin in Infantile Myofibromatosis With a Review of Treatment Options. J Pediatr Hematol Oncol. 2015 Apr; 37(3):237-41. View in: PubMed

Ocular abnormalities in patients treated with a novel anti-GD2 monoclonal antibody, hu14. 18K322A. J AAPOS. 2015 Apr; 19(2):112-5. View in: PubMed

The genomic landscape of childhood and adolescent melanoma. J Invest Dermatol. 2015 Mar; 135(3):816-823. View in: PubMed

Influence of bony resection margins and surgicopathological factors on outcomes in limb-sparing surgery for extremity osteosarcoma. Pediatr Blood Cancer. 2015 Feb; 62(2):246-251. View in: PubMed

Comparison of pain outcomes between two anti-GD2 antibodies in patients with neuroblastoma. Pediatr Blood Cancer. 2015 Feb; 62(2):224-228. View in: PubMed

An approach to renal masses in pediatrics. Pediatrics. 2015 Jan; 135(1):142-58. View in: PubMed

Long-term pulmonary function after metastasectomy for childhood osteosarcoma: a report from the St Jude lifetime cohort study. J Am Coll Surg. 2014 Aug; 219(2):265-71. View in: PubMed

Management of local recurrence of pediatric osteosarcoma following limb-sparing surgery. Ann Surg Oncol. 2014 Jun; 21(6):1948-55. View in: PubMed

Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosing. Clin Cancer Res. 2014 May 15; 20(10):2783-92. View in: PubMed

Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14. 18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma. J Clin Oncol. 2014 May 10; 32(14):1445-52. View in: PubMed

Safety of ultrasound contrast agents in the pediatric oncologic population: a single-institution experience. AJR Am J Roentgenol. 2014 May; 202(5):966-70. View in: PubMed

Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep. 2014 Apr 10; 7(1):104-12. View in: PubMed

A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors. Invest New Drugs. 2014 Feb; 32(1):171-7. View in: PubMed

Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patient with osteosarcoma. Pediatr Blood Cancer. 2014 Feb; 61(2):373-5. View in: PubMed

Alternative formulations of sorafenib for use in children. Pediatr Blood Cancer. 2013 Oct; 60(10):1642-6. View in: PubMed

Enhancement of the anti-melanoma response of Hu14. 18K322A by aCD40 + CpG. Cancer Immunol Immunother. 2013 Apr; 62(4):665-75. View in: PubMed

Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: a report from the St Jude lifetime cohort study. J Clin Oncol. 2013 Apr 01; 31(10):1324-8. View in: PubMed

Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors. Clin Cancer Res. 2013 Jan 01; 19(1):236-46. View in: PubMed

Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience. Ann Surg Oncol. 2012 Nov; 19(12):3816-22. View in: PubMed

Timing of surgery and the role of adjuvant radiotherapy in ewing sarcoma of the chest wall: a single-institution experience. Ann Surg Oncol. 2012 Nov; 19(12):3809-15. View in: PubMed

64Cu-p-NH2-Bn-DOTA-hu14. 18K322A, a PET radiotracer targeting neuroblastoma and melanoma. J Nucl Med. 2012 Nov; 53(11):1772-8. View in: PubMed

Clinical management of Ewing sarcoma of the bones of the hands and feet: a retrospective single-institution review. J Pediatr Surg. 2012 Oct; 47(10):1806-10. View in: PubMed

Disseminated carcinoma ex pleomorphic adenoma in an adolescent confirmed by application of PLAG1 immunohistochemistry and FISH for PLAG1 rearrangement. Head Neck Pathol. 2012 Sep; 6(3):377-83. View in: PubMed

Management of melanomas in children and young adults. J Pediatr Hematol Oncol. 2012 May; 34 Suppl 2:S51-4. View in: PubMed

Dose escalation of intravenous irinotecan using oral cefpodoxime: a phase I study in pediatric patients with refractory solid tumors. Pediatr Blood Cancer. 2012 Mar; 58(3):372-9. View in: PubMed

Jaw dysfunction related to pterygoid and masseter muscle dosimetry after radiation therapy in children and young adults with head-and-neck sarcomas. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):355-60. View in: PubMed

Genetic alterations in childhood melanoma. Am Soc Clin Oncol Educ Book. 2012; 589-92. View in: PubMed

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis. 2011 Nov 15; 204(10):1475-82. View in: PubMed

Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 01; 878(29):3033-8. View in: PubMed

Caveolin-1 modulates the ability of Ewing's sarcoma to metastasize. Mol Cancer Res. 2010 Nov; 8(11):1489-500. View in: PubMed

Anti-GD2 antibody therapy for GD2-expressing tumors. Curr Cancer Drug Targets. 2010 Mar; 10(2):200-9. View in: PubMed

Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcoma. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):874-8. View in: PubMed

Stability of cyclophosphamide in extemporaneous oral suspensions. Ann Pharmacother. 2010 Feb; 44(2):295-301. View in: PubMed

Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. Clin Cancer Res. 2010 Jan 15; 16(2):750-4. View in: PubMed

Body wall and visceral nonrhabdomyosarcoma soft tissue sarcomas in children and adolescents. J Pediatr Surg. 2009 Oct; 44(10):1965-71. View in: PubMed

Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors. J Clin Oncol. 2009 Sep 20; 27(27):4599-604. View in: PubMed

Sperm cryopreservation practices among adolescent cancer patients at risk for infertility. Pediatr Hematol Oncol. 2009 Jun; 26(4):252-60. View in: PubMed

Immune therapies for neuroblastoma. Cancer Biol Ther. 2009 May; 8(10):874-82. View in: PubMed

Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma. Cancer. 2008 Jul 15; 113(2):419-25. View in: PubMed

Stability of sunitinib in oral suspension. Ann Pharmacother. 2008 Jul; 42(7):962-6. View in: PubMed

Pulmonary nodules discovered during the initial evaluation of pediatric patients with bone and soft-tissue sarcoma. Pediatr Blood Cancer. 2008 Jun; 50(6):1147-53. View in: PubMed

Second cancers in patients with the Ewing sarcoma family of tumours. Eur J Cancer. 2008 May; 44(7):983-91. View in: PubMed

Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Ann Oncol. 2008 Apr; 19(4):814-20. View in: PubMed

Desmoplastic small round cell tumor in childhood: the St. Jude Children's Research Hospital experience. Pediatr Blood Cancer. 2007 Sep; 49(3):274-9. View in: PubMed

Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies. Cancer. 2007 Jul 15; 110(2):375-84. View in: PubMed

A model for quantitative changes in the magnetic resonance parameters of muscle in children after therapeutic irradiation. Magn Reson Imaging. 2006 Dec; 24(10):1319-24. View in: PubMed

Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells. Mol Cancer Ther. 2006 May; 5(5):1299-308. View in: PubMed

Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience. Cancer. 2006 Apr 15; 106(8):1846-56. View in: PubMed

STAT3 is activated in a subset of the Ewing sarcoma family of tumours. J Pathol. 2006 Apr; 208(5):624-32. View in: PubMed

The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma. Cancer. 2005 Feb 15; 103(4):780-7. View in: PubMed

Low Dose Histone Deacetylase Inhibitor, Depsipeptide (FR901228), Promotes Adenoviral Transduction in Human Rhabdomyosarcoma Cell Lines. Sarcoma. 2004; 8(1):25-30. View in: PubMed

Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nat Med. 2002 Nov; 8(11):1276-80. View in: PubMed

Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reaction. J Clin Oncol. 2001 Aug 15; 19(16):3649-59. View in: PubMed

Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein. Sarcoma. 2000; 4(3):93-102. View in: PubMed

Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. Leukemia. 1999 Jan; 13(1):135-41. View in: PubMed

AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma. Oncogene. 1998 Sep 10; 17(10):1261-70. View in: PubMed

Albumin, IgG, retinol-binding protein, and alpha1-microglobulin excretion in childhood. Pediatr Nephrol. 1998 May; 12(4):290-2. View in: PubMed

Powered bySC CTSI